These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28762539)

  • 1. The impact of antibody profile in thrombosis associated with primary antiphospholipid syndrome.
    da Silva Saraiva S; de Moraes Mazetto B; Quinteiro Tobaldine L; Pereira Colella M; Vinícius De Paula E; Annichinno-Bizzachi J; Andrade Orsi F
    Am J Hematol; 2017 Nov; 92(11):1163-1169. PubMed ID: 28762539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity of immune/clotting assays relate to multiple antiphospholipid antibody positivity in thrombotic primary antiphospholipid syndrome.
    Ames PRJ; Merashli M; Tommaso B; Iannaccone L; Marottoli V; Ciampa A
    Int J Hematol; 2021 Feb; 113(2):183-189. PubMed ID: 33030632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of antiphospholipid antibody levels and type on thrombotic manifestations: results from the Serbian National Cohort Study.
    Stojanovich L; Markovic O; Marisavljevic D; Elezovic I; Ilijevski N; Stanisavljevic N
    Lupus; 2012 Mar; 21(3):338-45. PubMed ID: 21993381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA anticardiolipin and IgA anti-β2 glycoprotein I antibody positivity determined by fluorescence enzyme immunoassay in primary antiphospholipid syndrome.
    Mattia E; Ruffatti A; Tonello M; Meneghel L; Robecchi B; Pittoni M; Gallo N; Salvan E; Teghil V; Punzi L; Plebani M
    Clin Chem Lab Med; 2014 Sep; 52(9):1329-33. PubMed ID: 24651022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.
    Andreoli L; Chighizola CB; Nalli C; Gerosa M; Borghi MO; Pregnolato F; Grossi C; Zanola A; Allegri F; Norman GL; Mahler M; Meroni PL; Tincani A
    Arthritis Rheumatol; 2015 May; 67(8):2196-204. PubMed ID: 25939498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABO blood group in primary antiphospholipid syndrome: influence in the site of thrombosis?
    Nascimento NM; Bydlowski SP; Soares RP; de Andrade DC; Bonfá E; Seguro LP; Borba EF
    J Thromb Thrombolysis; 2015 Oct; 40(3):374-8. PubMed ID: 25638331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low levels of vitamin D are common in primary antiphospholipid syndrome with thrombotic disease.
    Piantoni S; Andreoli L; Allegri F; Meroni PL; Tincani A
    Reumatismo; 2012 Dec; 64(5):307-13. PubMed ID: 23256106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pandemic influenza immunization in primary antiphospholipid syndrome (PAPS): a trigger to thrombosis and autoantibody production?
    de Medeiros DM; Silva CA; Bueno C; Ribeiro AC; Viana Vdos S; Carvalho JF; Bonfa E
    Lupus; 2014 Nov; 23(13):1412-6. PubMed ID: 24961747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies.
    Fredi M; Andreoli L; Aggogeri E; Bettiga E; Lazzaroni MG; Le Guern V; Lojacono A; Morel N; Piette JC; Zatti S; Costedoat-Chalumeau N; Tincani A
    Front Immunol; 2018; 9():864. PubMed ID: 29867924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombocytopenia as a thrombotic risk factor in patients with antiphospholipid antibodies without disease criteria.
    Demetrio Pablo R; Muñoz P; López-Hoyos M; Calvo V; Riancho L; Martínez-Taboada VM
    Med Clin (Barc); 2017 May; 148(9):394-400. PubMed ID: 28153433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-bound complement activation products in antiphospholipid antibody-positive patients without other systemic autoimmune rheumatic diseases.
    Erkan D; Vega J; O'Malley T; Concoff A
    Front Immunol; 2024; 15():1459842. PubMed ID: 39355252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
    Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
    Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistent triple antiphospholipid antibody positivity as a strong risk factor of first thrombosis, in a long-term follow-up study of patients without history of thrombosis or obstetrical morbidity.
    Yelnik CM; Urbanski G; Drumez E; Sobanski V; Maillard H; Lanteri A; Morell-Dubois S; Caron C; Dubucquoi S; Launay D; Duhamel A; Hachulla E; Hatron PY; Lambert M
    Lupus; 2017 Feb; 26(2):163-169. PubMed ID: 27432808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between non-thrombotic neurological and cardiac manifestations in patients with antiphospholipid syndrome.
    Stojanovich L; Kontic M; Smiljanic D; Djokovic A; Stamenkovic B; Marisavljevic D
    Clin Exp Rheumatol; 2013; 31(5):756-60. PubMed ID: 23899875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood Cell-Bound C4d as a Marker of Complement Activation in Patients With the Antiphospholipid Syndrome.
    Lonati PA; Scavone M; Gerosa M; Borghi MO; Pregnolato F; Curreli D; Podda G; Femia EA; Barcellini W; Cattaneo M; Tedesco F; Meroni PL
    Front Immunol; 2019; 10():773. PubMed ID: 31031764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic risk factors in primary antiphospholipid syndrome: a 5-year prospective study.
    Turiel M; Sarzi-Puttini P; Peretti R; Rossi E; Atzeni F; Parsons W; Doria A
    Stroke; 2005 Jul; 36(7):1490-4. PubMed ID: 15947270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS).
    Ceribelli A; Tincani A; Cavazzana I; Franceschini F; Cattaneo R; Pauley BA; Chan JY; Chan EK; Satoh M
    Autoimmunity; 2011 Mar; 44(2):90-7. PubMed ID: 20695766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of lupus anticoagulant and triple marker positivity as risk factors for rethrombosis in patients with primary antiphospholipid syndrome.
    Hernández-Molina G; Espericueta-Arriola G; Cabral AR
    Clin Exp Rheumatol; 2013; 31(3):382-8. PubMed ID: 23305633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.
    Montalvão S; Elídio PS; da Silva Saraiva S; de Moraes Mazetto B; Colella MP; de Paula EV; Appenzeller S; Annichino-Bizzacchi J; Orsi FA
    Thromb Res; 2016 Dec; 148():32-37. PubMed ID: 27770664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and analytical manifestations of primary antiphospholipid antibody syndrome].
    Camps García MT; Gutiérrez Rueda A; Guil García M; Perelló-González Moreno I; García Portales R; Belmonte López A; de Rámon Garrido E
    An Med Interna; 1993 Dec; 10(12):576-82. PubMed ID: 8049321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.